Ambev S.A. ABEV NYSE

Ambev S.A. (ABEV) generated $24.45B in operating cash flow for fiscal year 2025. After capital expenditures of $4.59B, free cash flow was $19.86B.

Free cash flow margin was 22.5% of revenue. Cash conversion ratio was 1.58x, indicating earnings are backed by cash.

The company returned $20.46B in dividends and $1.93B in share buybacks to shareholders during the period.

Criteria supported by this page:

• HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (88/100, Pass) — $19.86B (22.5% FCF margin) supports a durable competitive advantage
• INCOME (70/100) — Cash conversion ratio was 1.58x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 63/100 with 3/7 criteria passed.